Medical Ikkou Group Co Ltd operates in the Drug stores and proprietary stores sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Medical Ikkou Group Co Ltd with three other
drug stores in Asia:
Universal Health International Group Holding Ltd
of Hong Kong
sales of 2.78 billion Hong Kong Dollars [US$355.55 million]
of which 55%
Caring Pharmacy Group Bhd
(599.23 million Malaysian Ringgits [US$143.46 million]
of which 100%
was Pharmacy), and
Sapporo Clinical Laboratory Inc.
(17.07 billion Japanese Yen [US$156.83 million]
Medical Ikkou Group Co Ltd reported sales of ¥31.22 billion (US$286.93 million)
February of 2019.
a very small
increase of 1.0%
versus 2018, when the company's sales were ¥30.91 billion.
Sales at Medical Ikkou Group Co Ltd have increased during each of the previous five years
(and since 2014, sales have increased a total of 36%).
Sales of Drug Wholesaling saw an increase
that was more than double the company's growth rate: sales were up
6.2% in 2019, from
¥2.40 billion to ¥2.55 billion.
Medical Ikkou Group Co Ltd also saw significant increases in sales in
Healthcare (up 3.3% to ¥6.09 billion)
Not all segments of Medical Ikkou Group Co Ltd experienced an increase in sales in 2019:
sales of Real Estate fell 2.6% to ¥127.97 million.
(However, this segment's sales were only a very small portion of the company's overall sales).
Medical Ikkou Group Co Ltd also experienced decreases in sales in
Pharmacies (down 0.1% to ¥22.45 billion)